Internal Medicine, Hematology & Oncology · Johnstown, PA
NPI
1558367110
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
337 Somerset Street, UPMC Hillman Cancer Center
Johnstown, PA, 15901
Phone (814) 534-4724
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
69,766 services
Medicare patients, 2024
389
Average age 73
Drug cost, 2024
$11.2M
3,159 prescriptions
Company payments, 2025
$169
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ibrahim Sbeitan was code J9271 (injection, pembrolizumab, 1 mg), 9,800 times for 11 patients. In total Ibrahim Sbeitan billed 69,766 services in 96 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 9,800 | 11 | $44.22 | $433K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,425 | 20 | $0.22 | $311 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 830 | 18 | $0.09 | $76.42 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 540 | 13 | $0.77 | $414 |
| 99215 Office E&M - Established | Office | 397 | 146 | $116.26 | $46K |
| 99214 Office E&M - Established | Office | 384 | 246 | $79.77 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 263 | 185 | $12.40 | $3,260 |
| 96375 Injection Administration | Office | 185 | 31 | $11.25 | $2,082 |
| 96413 Chemotherapy Administration | Office | 184 | 35 | $93.86 | $17K |
| 96372 Injection Administration | Office | 115 | 25 | $10.66 | $1,226 |
| 96367 Intravenous Infusion, Hydration | Office | 113 | 23 | $20.79 | $2,349 |
| 99232 Hospital E&M - Subsequent | Facility | 88 | 38 | $59.31 | $5,219 |
| 96417 Chemotherapy Administration | Office | 69 | 16 | $46.37 | $3,199 |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 27 | $89.51 | $5,013 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 54 | 16 | $0.65 | $35.17 |
By year: 2022 $3.1M for 148,039 services; 2023 $3.0M for 135,576 services; 2024 $1.9M for 69,766 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ibrahim Sbeitan prescribed most often to Medicare patients was Anastrozole, with 356 prescriptions and refills. In total Ibrahim Sbeitan wrote 3,159 Medicare prescriptions that cost $11.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 356 | 578 | 82 | $7,506 |
| Acyclovir Generic | 210 | 260 | 51 | $2,489 |
| Eliquis Apixaban | 165 | 230 | 40 | $129K |
| Prednisone Generic | 153 | 180 | 59 | $428 |
| Allopurinol Generic | 140 | 190 | 32 | $3,223 |
| Ondansetron Hcl Generic | 140 | 142 | 96 | $3,192 |
| Dexamethasone Generic | 107 | 116 | 45 | $1,641 |
| Prochlorperazine Maleate Generic | 103 | 103 | 81 | $2,598 |
| Letrozole Generic | 93 | 137 | 24 | $1,275 |
| Potassium Chloride Generic | 86 | 111 | 26 | $1,403 |
| Erleada Apalutamide | 81 | 82 | 11 | $1.0M |
| Pantoprazole Sodium Generic | 79 | 129 | 20 | $726 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 78 | 106 | 14 | $203 |
| Imatinib Mesylate Generic | 63 | 63 | Under 11 | $250K |
| Exemestane Generic | 58 | 84 | 18 | $7,069 |
Brand drugs: - claims; generic drugs: 2,123 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ibrahim Sbeitan $169 ($169 in general payments such as food, travel and fees) from 3 companies. The largest payer was Adc Therapeutics America, Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.